Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Medoxomil vs Valsartan in Chinese Subjects with Essential Hypertension
NCT02480764Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Aug 2015; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02480764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480764.